Thalidomide

Trade Name: 
Thalomid
Manufacturer/Distributor: 
Celgene Canada
1-888-738-2431
Classification: 
Immunomodulatory agent
ATC Class: 
L04AX02 - Thalidomide
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2010/08/03
Date Marketed in Canada (yyyy/mm/dd): 
2010/08/06
Presentation: 
Capsule, 50 mg. DIN: 02355191
Capsule, 100 mg. DIN: 02355205
Capsule, 150 mg. DIN: 02355213
Capsule, 200 mg. DIN: 02355221
Comments: 
Approved for use incombination with melphalan and prednisone for the treatment of patients with previously untreated multiple myeloma who are 65 years of age or older. It may only be given to patients who had registered and meet all conditions of the RevAid program. RevAid is a controlled distribution program for this drug to minimize the risk of fetal exposure. Physicians and pharmacists must be registered and meet all the conditions of the program. Additional information can be obtained from www.revaid.ca or 1-888-738-2431.